We found that knockdown of NEDD4 profoundly impaired multiple cancer-related pathways using a cut-off suitable for exploratory discovery (P<0.05 and q<0.25, K–S test)30 (Fig. 6a and Supplementary Fig. 8a,b), indicating the potential role of NEDD4 in cancer13. This evidence concerns the gene NEDD4 and cancer.